ZYMENEX HOLDING ApS: Financial statements 2014
CVR: 21002348
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
ZYMENEX HOLDING ApS (CVR 21002348) has filed annual accounts for 2014. In 2014, the company reported a net result of DKK 3,778,274 compared with DKK 696,015 the year before. Equity in the 2014 report amounted to DKK 338,720,784. The solvency ratio was 99.5%.
- Profit/Loss
- DKK 3,778,274
- Equity
- DKK 338,720,784
- Total Assets
- DKK 340,406,688
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | - | 3.8 mio. | 338.7 mio. | - |
| 2013 | - | - | 696 t. | 303.7 mio. | - |
| 2012 | - | - | 773 t. | 288.1 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
ZYMENEX HOLDING ApS has published its annual report for 2013. The net result was DKK 696,015.
As of May 28, 2014, KPMG P/S has been appointed auditor of ZYMENEX HOLDING ApS.
As of May 28, 2014, EY Godkendt Revisionspartnerselskab has stepped down as auditor of ZYMENEX HOLDING ApS.
As of May 28, 2014, Danilo Piroli has joined the board of directors of ZYMENEX HOLDING ApS.
As of May 28, 2014, Paolo Patri has left the board of directors of ZYMENEX HOLDING ApS.
As of May 28, 2014, Mark Parry-Billings is registered as chairman of ZYMENEX HOLDING ApS.
As of May 28, 2014, Andrew Philip Dickinson has stepped down as chairman of ZYMENEX HOLDING ApS.
About ZYMENEX HOLDING ApS
ZYMENEX HOLDING ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 1998. The company has been dissolved on 3 December 2020. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named ZYMENEX HOLDING A/S and ZYMENEX A/S. The company has 0 employees (2013). In 2019, the company reported a gross profit of DKK 0 and a net result of DKK -729,000 compared with DKK 2,137,897 the year before. Equity in the 2019 report amounted to DKK 164,171,000.